Nie Wen-ying, Gong Lu-xia, Liu Yu-jun, Xiang Li-li, Lin Qian, Qi Yi-sheng, Nie Ying-jiu
Jinan Municipal Maternity and Child Care Center, Jinan 250000, China.
Zhonghua Yi Xue Za Zhi. 2003 Feb 25;83(4):274-7.
To investigate the results of hearing screening in newborns so as to explore the appropriate clinical strategy of hearing screening among newborns.
Transiently evoked otoacoustic emission (TEOAE) was used to examine the hearing of 10,501 newborns 2 - 4 days after birth. Those who failed the initial screening underwent secondary screening with TEOAE. Acoustic brain-stem response (ABR) and 40 Hz AERP were used to monitor the hearing of those who failed the secondary screening every 6 months since the age of 3 months to the age of 3 years.
The false-positive rate was 14.92% in the initial screening, and was 0.26% after the 2-stage screening. 62 infants were diagnosed with hearing loss with a prevalence of congenital hearing loss (in one ear or two ears) of 5.90 per thousand and a prevalence of bilateral hearing loss of 2.76 per thousand.
Hearing screening in the procedure with TEOAE, ABR and 40 Hz AERP helps identify infants with hearing loss as early as possible so as to conduct appropriate intervention.
探讨新生儿听力筛查结果,以探寻新生儿听力筛查的适宜临床策略。
采用瞬态诱发耳声发射(TEOAE)对10501例出生后2 - 4天的新生儿进行听力检查。初筛未通过者采用TEOAE进行复筛。对复筛未通过者,从3月龄至3岁,每6个月采用听性脑干反应(ABR)和40Hz听觉事件相关电位(40Hz AERP)进行听力监测。
初筛假阳性率为14.92%,两阶段筛查后为0.26%。62例婴儿被诊断为听力损失,先天性听力损失(单耳或双耳)患病率为千分之5.90,双侧听力损失患病率为千分之2.76。
采用TEOAE、ABR和40Hz AERP进行听力筛查有助于尽早发现听力损失婴儿,以便进行适当干预。